Cargando…
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a rapidly evolving pandemic worldwide with at least 68 million COVID-19-positive cases and a mortality rate of about 2.2%, as of 10 December 2020. About 20% of COVID-19 patients exhibit moderate...
Autores principales: | Ramasamy, Santhamani, Subbian, Selvakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142516/ https://www.ncbi.nlm.nih.gov/pubmed/33980688 http://dx.doi.org/10.1128/CMR.00299-20 |
Ejemplares similares
-
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
por: Nile, Shivraj Hariram, et al.
Publicado: (2020) -
A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
por: Kolloli, Afsal, et al.
Publicado: (2023) -
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
por: Ye, Qing, et al.
Publicado: (2020) -
Pathogenesis and treatment of cytokine storm in COVID-19
por: SOY, Mehmet, et al.
Publicado: (2021) -
Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)